1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Diabetes Associated Ophthalmic Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Diabetes Associated Ophthalmic Treatment Market, by Disease Type
8.1.1. Diabetic Retinopathy
8.1.1.1. Market Revenue and Forecast
8.1.2. Diabetic Macular Edema
8.1.2.1. Market Revenue and Forecast
8.1.3. Cataract Secondary to Diabetes
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Diabetes Associated Ophthalmic Treatment Market, by Treatment Type
9.1.1. Pharmaceuticals
9.1.1.1. Market Revenue and Forecast
9.1.2. Medical Devices
9.1.2.1. Market Revenue and Forecast
10.1. Diabetes Associated Ophthalmic Treatment Market, by Route of Administration
10.1.1. Intravitreal Injection
10.1.1.1. Market Revenue and Forecast
10.1.2. Topical Administration
10.1.2.1. Market Revenue and Forecast
10.1.3. Systemic Administration
10.1.3.1. Market Revenue and Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Forecast
11.1. Diabetes Associated Ophthalmic Treatment Market, by End-User
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Ophthalmology Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Ambulatory Surgical Centers
11.1.3.1. Market Revenue and Forecast
11.1.4. Homecare Settings
11.1.4.1. Market Revenue and Forecast
12.1. Diabetes Associated Ophthalmic Treatment Market, by Age Group
12.1.1. Pediatric Patients
12.1.1.1. Market Revenue and Forecast
12.1.2. Working-Age Adults
12.1.2.1. Market Revenue and Forecast
12.1.3. Elderly Patients
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Disease Type
13.1.2. Market Revenue and Forecast, by Treatment Type
13.1.3. Market Revenue and Forecast, by Route of Administration
13.1.4. Market Revenue and Forecast, by End-User
13.1.5. Market Revenue and Forecast, by Age Group
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Disease Type
13.1.6.2. Market Revenue and Forecast, by Treatment Type
13.1.6.3. Market Revenue and Forecast, by Route of Administration
13.1.6.4. Market Revenue and Forecast, by End-User
13.1.6.5. Market Revenue and Forecast, by Age Group
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Disease Type
13.1.7.2. Market Revenue and Forecast, by Treatment Type
13.1.7.3. Market Revenue and Forecast, by Route of Administration
13.1.7.4. Market Revenue and Forecast, by End-User
13.1.7.5. Market Revenue and Forecast, by Age Group
13.2. Europe
13.2.1. Market Revenue and Forecast, by Disease Type
13.2.2. Market Revenue and Forecast, by Treatment Type
13.2.3. Market Revenue and Forecast, by Route of Administration
13.2.4. Market Revenue and Forecast, by End-User
13.2.5. Market Revenue and Forecast, by Age Group
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Disease Type
13.2.6.2. Market Revenue and Forecast, by Treatment Type
13.2.6.3. Market Revenue and Forecast, by Route of Administration
13.2.7. Market Revenue and Forecast, by End-User
13.2.8. Market Revenue and Forecast, by Age Group
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Disease Type
13.2.9.2. Market Revenue and Forecast, by Treatment Type
13.2.9.3. Market Revenue and Forecast, by Route of Administration
13.2.10. Market Revenue and Forecast, by End-User
13.2.11. Market Revenue and Forecast, by Age Group
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Disease Type
13.2.12.2. Market Revenue and Forecast, by Treatment Type
13.2.12.3. Market Revenue and Forecast, by Route of Administration
13.2.12.4. Market Revenue and Forecast, by End-User
13.2.13. Market Revenue and Forecast, by Age Group
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Disease Type
13.2.14.2. Market Revenue and Forecast, by Treatment Type
13.2.14.3. Market Revenue and Forecast, by Route of Administration
13.2.14.4. Market Revenue and Forecast, by End-User
13.2.15. Market Revenue and Forecast, by Age Group
13.3. APAC
13.3.1. Market Revenue and Forecast, by Disease Type
13.3.2. Market Revenue and Forecast, by Treatment Type
13.3.3. Market Revenue and Forecast, by Route of Administration
13.3.4. Market Revenue and Forecast, by End-User
13.3.5. Market Revenue and Forecast, by Age Group
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Disease Type
13.3.6.2. Market Revenue and Forecast, by Treatment Type
13.3.6.3. Market Revenue and Forecast, by Route of Administration
13.3.6.4. Market Revenue and Forecast, by End-User
13.3.7. Market Revenue and Forecast, by Age Group
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Disease Type
13.3.8.2. Market Revenue and Forecast, by Treatment Type
13.3.8.3. Market Revenue and Forecast, by Route of Administration
13.3.8.4. Market Revenue and Forecast, by End-User
13.3.9. Market Revenue and Forecast, by Age Group
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Disease Type
13.3.10.2. Market Revenue and Forecast, by Treatment Type
13.3.10.3. Market Revenue and Forecast, by Route of Administration
13.3.10.4. Market Revenue and Forecast, by End-User
13.3.10.5. Market Revenue and Forecast, by Age Group
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Disease Type
13.3.11.2. Market Revenue and Forecast, by Treatment Type
13.3.11.3. Market Revenue and Forecast, by Route of Administration
13.3.11.4. Market Revenue and Forecast, by End-User
13.3.11.5. Market Revenue and Forecast, by Age Group
13.4. MEA
13.4.1. Market Revenue and Forecast, by Disease Type
13.4.2. Market Revenue and Forecast, by Treatment Type
13.4.3. Market Revenue and Forecast, by Route of Administration
13.4.4. Market Revenue and Forecast, by End-User
13.4.5. Market Revenue and Forecast, by Age Group
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Disease Type
13.4.6.2. Market Revenue and Forecast, by Treatment Type
13.4.6.3. Market Revenue and Forecast, by Route of Administration
13.4.6.4. Market Revenue and Forecast, by End-User
13.4.7. Market Revenue and Forecast, by Age Group
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Disease Type
13.4.8.2. Market Revenue and Forecast, by Treatment Type
13.4.8.3. Market Revenue and Forecast, by Route of Administration
13.4.8.4. Market Revenue and Forecast, by End-User
13.4.9. Market Revenue and Forecast, by Age Group
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Disease Type
13.4.10.2. Market Revenue and Forecast, by Treatment Type
13.4.10.3. Market Revenue and Forecast, by Route of Administration
13.4.10.4. Market Revenue and Forecast, by End-User
13.4.10.5. Market Revenue and Forecast, by Age Group
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Disease Type
13.4.11.2. Market Revenue and Forecast, by Treatment Type
13.4.11.3. Market Revenue and Forecast, by Route of Administration
13.4.11.4. Market Revenue and Forecast, by End-User
13.4.11.5. Market Revenue and Forecast, by Age Group
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Disease Type
13.5.2. Market Revenue and Forecast, by Treatment Type
13.5.3. Market Revenue and Forecast, by Route of Administration
13.5.4. Market Revenue and Forecast, by End-User
13.5.5. Market Revenue and Forecast, by Age Group
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Disease Type
13.5.6.2. Market Revenue and Forecast, by Treatment Type
13.5.6.3. Market Revenue and Forecast, by Route of Administration
13.5.6.4. Market Revenue and Forecast, by End-User
13.5.7. Market Revenue and Forecast, by Age Group
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Disease Type
13.5.8.2. Market Revenue and Forecast, by Treatment Type
13.5.8.3. Market Revenue and Forecast, by Route of Administration
13.5.8.4. Market Revenue and Forecast, by End-User
13.5.8.5. Market Revenue and Forecast, by Age Group
14.1. Alcon
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Johnson & Johnson Services, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Bausch Health
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. F. Hoffmann-La Roche Ltd
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Allergan
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bayer AG
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Santen Pharmaceutical Co. Ltd.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Novartis AG
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Pfizer, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Genentech, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
